Benzinga | Nov 12, 2020 04:13PM EST

Catabasis Pharmaceuticals Q3 EPS $(0.56), Same YoY

Catabasis Pharmaceuticals (NASDAQ:CATB) reported quarterly losses of $(0.56) per share. This is unchanged from the same period last year.